Sally J. York

811 total citations
22 papers, 600 citations indexed

About

Sally J. York is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sally J. York has authored 22 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Sally J. York's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sally J. York is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sally J. York collaborates with scholars based in United States, Switzerland and Taiwan. Sally J. York's co-authors include Paul Modrich, John D. York, Thomas D. Petes, Patricia W. Greenwell, Blaine N. Armbruster, Nancy Dahms, Walter Gregory, Lynne S. Arneson, Stuart Kornfeld and Christine M. Lovly and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Sally J. York

21 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sally J. York United States	10	321	244	150	126	104	22	600
Makoto Iimori Japan	17	409 1.3×	342 1.4×	106 0.7×	120 1.0×	148 1.4×	31	664
Yingying Liang China	15	426 1.3×	341 1.4×	187 1.2×	252 2.0×	26 0.3×	29	851
Petra Laspe Germany	14	325 1.0×	104 0.4×	43 0.3×	109 0.9×	40 0.4×	19	564
Tiziana Tonini United States	11	431 1.3×	229 0.9×	53 0.4×	143 1.1×	47 0.5×	15	646
Karen G. Spink United Kingdom	10	392 1.2×	278 1.1×	177 1.2×	169 1.3×	20 0.2×	13	722
Nicolas Skrypek France	11	485 1.5×	374 1.5×	60 0.4×	173 1.4×	54 0.5×	13	815
Frauke Goeman Italy	18	407 1.3×	161 0.7×	56 0.4×	186 1.5×	26 0.3×	32	625
Joan Fernando Spain	7	334 1.0×	192 0.8×	44 0.3×	128 1.0×	56 0.5×	8	532
Jingshu Geng China	19	484 1.5×	317 1.3×	79 0.5×	167 1.3×	36 0.3×	36	777
Tamer Yağcı Türkiye	13	357 1.1×	274 1.1×	53 0.4×	162 1.3×	32 0.3×	32	550

Countries citing papers authored by Sally J. York

Since Specialization

Citations

This map shows the geographic impact of Sally J. York's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally J. York with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally J. York more than expected).

Fields of papers citing papers by Sally J. York

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally J. York. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally J. York. The network helps show where Sally J. York may publish in the future.

Co-authorship network of co-authors of Sally J. York

This figure shows the co-authorship network connecting the top 25 collaborators of Sally J. York. A scholar is included among the top collaborators of Sally J. York based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally J. York. Sally J. York is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lewis, Jennifer A., Jacquelyn S. Pennings, Lauren R. Samuels, et al.. (2025). National Survey of Lung Cancer Screening Eligibility in United States Veterans. American Journal of Preventive Medicine. 68(5). 886–895. 1 indexed citations

Hackstadt, Amber J., Daniel Park, Robert J. Winter, et al.. (2025). Validation of data in the Veteran health administration electronic medical record for identification of tobacco use. Annals of Epidemiology. 110. 167–171.

Itzstein, Mitchell S. von, Timothy F. Burns, Jonathan E. Dowell, et al.. (2024). Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS -Mutant Non–Small Cell Lung Cancer. Clinical Cancer Research. 31(4). 639–648. 1 indexed citations

Itzstein, Mitchell S. von, Timothy F. Burns, Jonathan E. Dowell, et al.. (2024). Phase 1/2 trial of the XPO1 inhibitor selinexor in combination with docetaxel in previously treated, advanced KRAS mutant non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 42(16_suppl). 8597–8597. 1 indexed citations

Fahey, Catherine C., Caroline A. Nebhan, Sally J. York, et al.. (2023). Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin. International Journal of Molecular Sciences. 24(22). 16109–16109. 11 indexed citations

Lewis, Jennifer A., Kemberlee Bonnet, David G. Schlundt, et al.. (2023). Rural barriers and facilitators of lung cancer screening program implementation in the veterans health administration: a qualitative study. Frontiers in Health Services. 3. 1209720–1209720. 1 indexed citations

Lander, Eric, Xuanyi Li, Li‐Ching Huang, et al.. (2023). Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer. Journal of the National Comprehensive Cancer Network. 21(10). 1050–1057.e13. 3 indexed citations

Huang, Li‐Ching, Jennifer G. Whisenant, Sally J. York, et al.. (2022). Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors. ERJ Open Research. 8(4). 684–2021. 1 indexed citations

Iams, Wade T., Prasad Kopparapu, Yingjun Yan, et al.. (2020). Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease. JTO Clinical and Research Reports. 1(2). 100024–100024. 16 indexed citations

10.

Sheth, Vipul, Vanessa E. Kennedy, Hugues de Lavallade, et al.. (2019). Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience. Frontiers in Oncology. 9. 623–623. 3 indexed citations

11.

Johnson, Douglas B., Sally J. York, Michael N. Neuss, et al.. (2018). Impact of the influenza vaccination on cancer patients undergoing therapy with immune checkpoint inhibitors (ICI).. Journal of Clinical Oncology. 36(15_suppl). 3053–3053. 13 indexed citations

12.

Iams, Wade T., Catherine B. Meador, Sally J. York, et al.. (2017). Longitudinal monitoring of circulating tumor DNA and peripheral T cell repertoire in patients with small cell lung cancer.. Journal of Clinical Oncology. 35(15_suppl). 8571–8571. 1 indexed citations

13.

Iams, Wade T., Catherine B. Meador, Zhiguo Zhao, et al.. (2017). Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse. Journal of Thoracic Oncology. 13(1). 112–123. 105 indexed citations

14.

Leger, Paul, et al.. (2017). Response to salvage chemotherapy following exposure to immune checkpoint inhibitors in patients with non-small cell lung cancer.. Journal of Clinical Oncology. 35(15_suppl). 9084–9084. 43 indexed citations

15.

Rothschild, Sacha I., et al.. (2017). Response to salvage chemotherapy following exposure to PD-1/PD-L1 inhibitors in patients with NSCLC. Annals of Oncology. 28. ii33–ii33. 8 indexed citations

16.

Gallant, Jean‐Nicolas, Jonathan H. Sheehan, Timothy M. Shaver, et al.. (2015). EGFR Kinase Domain Duplication ( EGFR -KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib. Cancer Discovery. 5(11). 1155–1163. 81 indexed citations

17.

York, Sally J. & Paul Modrich. (2006). Mismatch Repair-dependent Iterative Excision at Irreparable O6-Methylguanine Lesions in Human Nuclear Extracts. Journal of Biological Chemistry. 281(32). 22674–22683. 72 indexed citations

18.

York, Sally J., Blaine N. Armbruster, Patricia W. Greenwell, Thomas D. Petes, & John D. York. (2004). Inositol Diphosphate Signaling Regulates Telomere Length. Journal of Biological Chemistry. 280(6). 4264–4269. 129 indexed citations

19.

York, Sally J., Lynne S. Arneson, Walter Gregory, Nancy Dahms, & Stuart Kornfeld. (1999). The Rate of Internalization of the Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is Enhanced by Multivalent Ligand Binding. Journal of Biological Chemistry. 274(2). 1164–1171. 87 indexed citations

20.

Moseley, Pope, Sally J. York, & John D. York. (1989). Bleomycin Induces the Hsp 70 Heat Shock Promoter in Cultured Cells. American Journal of Respiratory Cell and Molecular Biology. 1(2). 89–93. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact